Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sizemore

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Tuberculosis (Edinburgh, Scotland)|March 24, 2012
Transforming biomedical research to develop effective TB vaccines: the next ten yearsChristine F Sizemore, Anthony S Fauci
Materials Management in Health Care|June 3, 1999
To choose the best sterilization technology ... ask away!V Coffey, N Danielson, F Sizemore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2016
Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental ResearchChristian Lienhardt, Alison M Kraigsley, Christine F Sizemore
Expert Opinion on Biological Therapy|September 1, 2004
Tuberculosis vaccine development: research, regulatory and clinical strategiesMichael J Brennan, Sheldon L Morris, Christine F Sizemore
Emerging Microbes & Infections|June 4, 2015
The role of biomedical research in global tuberculosis control: gaps and challenges: A perspective from the US National Institute of Allergy and Infectious Diseases, National Institutes of HealthChristine F Sizemore, Amanda C Schleif, Jessica B Bernstein, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection modelChristine F Sizemore, Joel D Quispe, Karen M Amsler, et al.
Nature Biotechnology|May 1, 2002
An array of target-specific screening strains for antibacterial discoveryJoseph A DeVito, Jonathan A Mills, Veronica G Liu, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Glutamyl-gamma-boronate inhibitors of bacterial Glu-tRNA(Gln) amidotransferaseC P Decicco, D J Nelson, Y Luo, et al.
Plos Medicine|March 3, 2016
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and ActionsChristian Lienhardt, Knut Lönnroth, Dick Menzies, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2018
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for ResearchShelby Daniel-Wayman, Getahun Abate, Daniel L Barber, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Tuberculosis (Edinburgh, Scotland)|March 24, 2012
Transforming biomedical research to develop effective TB vaccines: the next ten yearsChristine F Sizemore, Anthony S Fauci
Materials Management in Health Care|June 3, 1999
To choose the best sterilization technology ... ask away!V Coffey, N Danielson, F Sizemore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2016
Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental ResearchChristian Lienhardt, Alison M Kraigsley, Christine F Sizemore
Expert Opinion on Biological Therapy|September 1, 2004
Tuberculosis vaccine development: research, regulatory and clinical strategiesMichael J Brennan, Sheldon L Morris, Christine F Sizemore
Emerging Microbes & Infections|June 4, 2015
The role of biomedical research in global tuberculosis control: gaps and challenges: A perspective from the US National Institute of Allergy and Infectious Diseases, National Institutes of HealthChristine F Sizemore, Amanda C Schleif, Jessica B Bernstein, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection modelChristine F Sizemore, Joel D Quispe, Karen M Amsler, et al.
Nature Biotechnology|May 1, 2002
An array of target-specific screening strains for antibacterial discoveryJoseph A DeVito, Jonathan A Mills, Veronica G Liu, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Glutamyl-gamma-boronate inhibitors of bacterial Glu-tRNA(Gln) amidotransferaseC P Decicco, D J Nelson, Y Luo, et al.
Plos Medicine|March 3, 2016
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and ActionsChristian Lienhardt, Knut Lönnroth, Dick Menzies, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2018
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for ResearchShelby Daniel-Wayman, Getahun Abate, Daniel L Barber, et al.
Pageof 1